drugset / Trial / NCT00546442

Treatment Insulin Resistence in HCV G-1 Patient

NCT00546442 ↗

Phase 4 Completed 126 enrolled Valme University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the effect of treatment of insulin resistance in the response of chronic hepatitis C treatment, mesure as HCV-RNA negative at week 72. 4.3.2 Objetivos secundarios To evaluate the efficacy and safety of treatment with metformine to erradicate the insulin resistance of patients with chornic hepatitis C genotype 1 measure as HOMA-IR \< 2.

Timeline

Start
2006-05
Primary completion
—
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg —
Subject Metformin Small molecule 2550 mg —